Search












The lists contain medicinal products or product categories subject to prescription which shall not bear the safety features (White list) and medicinal products or product categories not subject to prescription which shall bear the safety features (Black list)
Number of records: 5289
Name of the medicinal product Supplement
SÚKL code Registration Number SPC ? PIL ? ATC group MA status ?
XELJANZ 10MG TBL FLM 180
0223059 EU/1/17/1178/006 xeljanz.pdf xeljanz.pdf L04AA29 R
XELJANZ 10MG TBL FLM 56
0223060 EU/1/17/1178/007 xeljanz.pdf xeljanz.pdf L04AA29 R
XELJANZ 10MG TBL FLM 112
0223061 EU/1/17/1178/008 xeljanz.pdf xeljanz.pdf L04AA29 R
XELJANZ 10MG TBL FLM 182
0223062 EU/1/17/1178/009 xeljanz.pdf xeljanz.pdf L04AA29 R
XELJANZ 5MG TBL FLM 180
0222097 EU/1/17/1178/002 xeljanz.pdf xeljanz.pdf L04AA29 R
XELJANZ 11MG TBL PRO 28
0238763 EU/1/17/1178/012 xeljanz.pdf xeljanz.pdf L04AA29 R
XELJANZ 11MG TBL PRO 90
0238762 EU/1/17/1178/011 xeljanz.pdf xeljanz.pdf L04AA29 R
XELJANZ 11MG TBL PRO 30
0238761 EU/1/17/1178/010 xeljanz.pdf xeljanz.pdf L04AA29 R
XELJANZ 5MG TBL FLM 112
0238242 EU/1/17/1178/014 xeljanz.pdf xeljanz.pdf L04AA29 R
XELJANZ 1MG/ML POR SOL 1X240ML+STŘ
0255176 EU/1/17/1178/015 xeljanz.pdf xeljanz.pdf L04AA29 R
XELODA 150MG TBL FLM 60(6X10)
0027023 EU/1/00/163/001 xeloda.pdf xeloda.pdf L01BC06 R
XELODA 500MG TBL FLM 120(12X10)
0027024 EU/1/00/163/002 xeloda.pdf xeloda.pdf L01BC06 R
XOSPATA 40MG TBL FLM 84
0238673 EU/1/19/1399/001 xospata.pdf xospata.pdf L01EX13 R
XROMI 100MG/ML POR SOL 1X150ML+ADAP+2STŘ
0238543 EU/1/19/1366/001 xromi.pdf xromi.pdf L01XX05 R
XTANDI 40MG TBL FLM 112
0222450 EU/1/13/846/002 xtandi.pdf xtandi.pdf L02BB04 R
XTANDI 40MG CPS MOL 112
0194246 EU/1/13/846/001 xtandi.pdf xtandi.pdf L02BB04 R
XTANDI 80MG TBL FLM 56
0222451 EU/1/13/846/003 xtandi.pdf xtandi.pdf L02BB04 R
YERVOY 5MG/ML INF CNC SOL 1X40ML
0185102 EU/1/11/698/002 yervoy.pdf yervoy.pdf L01FX04 R
YERVOY 5MG/ML INF CNC SOL 1X10ML
0185101 EU/1/11/698/001 yervoy.pdf yervoy.pdf L01FX04 R
YESCARTA 0,4-2X10^8BUNĚK INF DIS 1X68ML
0223073 EU/1/18/1299/001 yescarta.pdf yescarta.pdf L01XX70 R

‹‹ ‹ 100 200 210 220 230 240 250 255 256 257 258 259 260 261 262 263 264 265 › ››

Medicinal products reimbursed from health insurance are blue-tinged and marked with sign.

Medicinal products on the Czech market in line with periodical report from wholesalers in last 3 months (with monthly distance) are sign and are typed in bold

Last update of registration information: 18. January 2022 at 00:08
Last update of price and payment data: 1. January 2022 at 00:11